OmniAb (OABI) Total Non-Current Liabilities (2021 - 2026)

OmniAb (OABI) reported Total Non-Current Liabilities of $30.9 million for Q1 2026, down 5.06% year-over-year from $32.6 million in Q1 2025, and down 8.52% quarter-over-quarter from $33.8 million in Q4 2025.

OmniAb (OABI) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Total Non-Current Liabilities data on file, last reported at $30.9 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $30.9 million, down 5.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.9 million (down 5.06% YoY), and the FY2025 annual result was $33.8 million, down 10.69% from the prior year.
  • Total Non-Current Liabilities fell to $30.9 million in Q1 2026 per OABI's latest filing, from $33.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $79.8 million in Q4 2022 and troughed at $30.9 million in Q1 2026.
  • A 5-year average of $48.2 million and a median of $40.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities climbed 22.13% in 2022, then plunged 38.44% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $79.8 million in 2022, then declined by 28.02% to $57.4 million in 2023, then sank by 34.09% to $37.9 million in 2024, then dropped by 10.69% to $33.8 million in 2025, then retreated by 8.52% to $30.9 million in 2026.
  • Business Quant data shows OABI's Total Non-Current Liabilities at $30.9 million in Q1 2026, $33.8 million in Q4 2025, and $31.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 30.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.93 Mn
Dec 31, 2025 33.81 Mn
Sep 30, 2025 31.73 Mn
Jun 30, 2025 33.53 Mn
Mar 31, 2025 32.58 Mn
Dec 31, 2024 37.85 Mn
Sep 30, 2024 39.77 Mn
Jun 30, 2024 41.89 Mn
Mar 31, 2024 51.13 Mn
Dec 31, 2023 57.44 Mn
Sep 30, 2023 63.64 Mn
Jun 30, 2023 68.05 Mn
Mar 31, 2023 72.20 Mn
Dec 31, 2022 79.79 Mn
Dec 31, 2021 65.33 Mn